|
Merck & Company, Inc.
|
One Merck Drive
Whitehouse Station, NJ 08889-3400
United States |
| Tel: |
1/908 423-1000 |
| URL: |
http://www.merck.com |
|
 |
| Primary Symbols & Exchanges: |
| MRK - New York Stock Exchange |
|
|
| Primary Industry: |
| Pharmaceutical |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activity is to develop, manufacture and market a broad range of innovative products to improve human and animal health. The products of the Group are sold primarily to drug wholesalers and retailers, hospitals, clinics, government agencies and health care providers such as health maintenance organizations and other institutions. Some of the important products of the Group include Arcoxia, Cancidas, Comvax, Cosopt, Cozaar, Crixivan, Emend, Fosamax, Hyzaar, Invanz, Maxalt, PedvaxHIB, Primaxin, Propecia, Proscar, Recombivax HB, Singulair, Timoptic-XE , Trusopt, Vioxx and Zocor. The Group has operations in the United States, Europe, Middle East, Africa and Japan. The Group acquired NovaCardia, Inc in September 2007. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Merck & Company, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
